-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 4, the U.
This approval is based on positive results from a randomized, double-blind, placebo-controlled Phase 3 clinical trial
Image source: Merck's official website
Patients with stage IIB or IIC melanoma carry deep or ulcerated tumors in situ
The use of Keytruda in the treatment of patients with earlier stage cancer is one of the important directions of research and development of Merck & Co.
Note: The original text has been deleted
References:
[1] FDA Approves Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma.
[2] Keytruda Label.